Three Healthcare Organizations Join Forces to Save Lives
A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder
Healthy People 2030 Leveraging Healthy People to Advance Health Equity Health equity is the attainment of the highest level of health for all people. “Eliminate health disparities, achieve health equity, and attain health literacy to improve the health and well-being of all.”
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…
FDA approves 1 Year delay of Track & Trace requirements
NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.
Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.
NOVA ScriptsCentral is excited to collaborate with the American Pharmacist Association to launch the “NOVA ScriptsCentral & American Pharmacist Association Safety-Net Health Equity Fellowship”.
How a ‘weighted lottery’ helped underserved patients get a scarce Covid drug
The pharmacy industry sees at least five changes
Just as banks have helped seniors bridge the digital divide and leverage online banking to better manage their money, healthcare organizations need to help older adults leverage digital technology to better manage their health.
This study represents a rigorous, multi-state evaluation that highlights the impact of a charitable medication access program on hospital utilization for the medically under-served population.
How is a charitable pharmacy different from other types of pharmacies?
The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023